Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
676
North
Sai
nt C
lair,
Sui
te 1
200
Chic
ago,
Illin
ois
6061
1
VISIT OUR WEBSITE lynnsagebreastcancer.org
19TH ANNUAL
LYNN SAGE BREAST CANCER SYMPOSIUM SEPTEMBER 14-17, 2017Chicago Marriott Downtown Magnificent Mile
SYMPOSIUM CHAIR William Gradishar, MD
SYMPOSIUM CO-CHAIRS Monica Morrow, MD V. Craig Jordan, OBE, PhD, DSc Nora Hansen, MD
Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium provides 3.5 days of formal presentations and interactive case discussions. For 19 years, this multidisciplinary CME program has been bringing together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.
Progress across all aspects of patient care, including prevention, screening, detection, and survivorship, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, and novel biologic therapies are leading to new strategies and therapeutic options. The symposium focuses on the close cooperation required for effective multidisciplinary management of patients with breast cancer.
Educational Objectives
At the conclusion of this activity, participants will be able to:
» Practice current management approaches to high-risk benign breast lesions.
» Describe factors influencing the choice of initial therapeutic approaches— neoadjuvant chemotherapy, mastectomy or oncoplastic breast conservation in operable breast cancer.
» Identify the multidisciplinary challenges and opportunities associated with the use of neoadjuvant chemotherapy in operable breast cancer.
» Apply optimal pain management strategies in patients with breast cancer.
» Employ optimal strategies for overcoming endocrine resistance by incorporating targeted therapies.
» Cite the clinical and molecular factors that determine the optimal duration of adjuvant endocrine therapy.
» Utilize optimal surgical and medical interventions in the elderly with breast cancer.
PROGRAM DESCRIPTION
CONFIRMED FACULTY
Benjamin Anderson, MD University of Washington
Jose Baselga, MD, PhD Memorial Sloan Kettering Cancer Center
Richard Bleicher, MD Fox Chase Cancer Center
Thomas Buccholz, MD The University of Texas MD Anderson Cancer Center
Harold Burstein, MD, PhD Harvard Medical School
Massimo Cristofanilli, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Sarah Friedewald, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
William Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Nora Hansen, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Kevin Hughes, MD Massachusetts General Hospital
Arti Hurria, MD City of Hope
Reshma Jagsi, MD, PhD University of Michigan
V. Craig Jordan, OBE, PhD, DSc The University of Texas MD Anderson Cancer Center
Malcolm Kell, MD Mater Misericordiae University Hospital
Seema Khan, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
John Kim, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Tari King, MD Dana-Farber Cancer Institute of Harvard Medical School
Jennifer Ligibel, MD Harvard University
Elizabeth Mittendorf, MD, PhD The University of Texas MD Anderson Cancer Center
Monica Morrow, MD Memorial Sloan Kettering Cancer Center
Hyman Muss, MD University of North Carolina Lineberger Comprehensive Cancer Center
Ruth O’Regan, MD University of Wisconsin Carbone Cancer Center
Joyce O’Shaughnessy, MD Texas Oncology & US Oncology/ Baylor Sammans Cancer Center
Judith Paice, PhD, RN Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lajos Pusztai, MD Yale University
Abram Recht, MD Beth Israel Deaconess Medical Center/ Harvard Medical School
Mark Robson, MD Memorial Sloan Kettering Cancer Center
Stuart Schnitt, MD Beth Israel Deaconess Medical Center/ Harvard Medical School
Andrew Seidman, MD Memorial Sloan Kettering Cancer Center
Kalliopi Siziopikou, MD, PhD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Dennis Sgroi, MD Massachusetts General Hospital
Lawrence Solin, MD Albert Einstein Healthcare Network
Fraser Symmans, MD The University of Texas MD Anderson Cancer Center
Melinda Telli, MD Stanford University
Julia Trosman, PhD, MBA Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Gary Ulaner, MD Memorial Sloan Kettering Cancer Center
Conf
eren
ce L
ocat
ion
and
Acco
mm
odat
ions
Th
e Ch
icag
o M
arrio
tt Do
wnto
wn M
agni
ficen
t Mile
is
con
veni
ently
loca
ted
in th
e he
art o
f dow
ntow
n Ch
icag
o at
540
N. M
ichi
gan
Aven
ue. A
lim
ited
num
ber o
f gue
st ro
oms
have
bee
n he
ld fo
r Sym
posi
um
atte
ndee
s at
the
disc
ount
ed ra
te o
f $27
7 pl
us ta
x pe
r nig
ht th
roug
h Au
gust
23,
201
7. C
onta
ct th
e ho
tel d
irect
ly at
312
.836
.010
0 or
use
the
link
on
our w
ebsi
te. M
entio
n th
e Ly
nn S
age
Brea
st C
ance
r Sy
mpo
sium
for t
he re
duce
d ra
te.
Spec
ial A
ssis
tanc
e In
com
plia
nce
with
the
Amer
ican
s wi
th D
isab
ilitie
s Ac
t, No
rthwe
ster
n Un
iver
sity
will
mak
e al
l rea
sona
ble
effo
rts to
acc
omm
odat
e pe
rson
s wi
th d
isab
ilitie
s at
th
is m
eetin
g. A
dditi
onal
ly, if
you
have
any
spe
cial
di
etar
y res
trict
ions
, ple
ase
notif
y our
offi
ce a
t 31
2.69
5.13
92 p
rior t
o th
e co
nfer
ence
.
Accr
edita
tion
Stat
emen
t Th
e No
rthwe
ster
n Un
iver
sity
Fei
nber
g Sc
hool
of
Med
icin
e is
acc
redi
ted
by th
e Ac
cred
itatio
n Co
unci
l fo
r Con
tinui
ng M
edic
al E
duca
tion
(ACC
ME)
to p
rovi
de
cont
inui
ng m
edic
al e
duca
tion
for p
hysi
cian
s.
Cred
it De
sign
atio
n St
atem
ent
The
North
west
ern
Univ
ersi
ty F
einb
erg
Scho
ol o
f M
edic
ine
desi
gnat
es th
is li
ve a
ctiv
ity fo
r a m
axim
um
of 2
1.5
AMA
PRA
Cate
gory
1 C
redi
t(s)™
. Phy
sici
ans
shou
ld c
laim
onl
y the
cre
dit c
omm
ensu
rate
with
the
exte
nt o
f the
ir pa
rtici
patio
n in
the
activ
ity.
Othe
r Cre
dits
Th
e Am
eric
an A
cade
my o
f Nur
se P
ract
ition
ers
and
the
Amer
ican
Nur
ses
Cred
entia
ling
Cent
er a
ccep
t AM
A PR
A Ca
tego
ry 1
Cre
dits
(s)™
from
org
aniza
tions
ac
cred
ited
by th
e AC
CME.
For a
dditi
onal
info
rmat
ion
or to
regi
ster
vis
it ly
nnsa
gebr
east
canc
er.o
rg
or c
all 3
12.6
95.1
392.
Register by July 31, 2017 for early bird discount
Faculty Disclosure Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker’s presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off–label usage will be indicated in the course syllabus.
SEPTEMBER 14 THURSDAY8:00 am Breakfast & Exhibits
9:00 am Symposium Welcome William Gradishar, MD Symposium Chair
Session 1: Supportive Issues or Art of Oncology Session Chair: Nora Hansen, MD
9:15 am Current Pain Management Guidelines Judith Paice, PhD, RN
9:45 am The Imperative of Mandated Care Models Julia Trosman, PhD, MBA
10:15 am Exercise, Diet, Obesity, and Breast Cancer Jennifer Ligibel, MD
10:45 am Break
11:00 am Computer-Based Physician Support in Breast Cancer Decision Making Andrew Seidman, MD
11:30 am Questions and Answers
11:45 am Lunch Break
Session 2: Breast Pathology for the Non-Pathologist Session Chair: Kalliopi Siziopikou, MD, PhD
1:00 pm Do All High Risk Lesions Still Require Surgical Excision? Stuart Schnitt, MD
1:30 pm Classic and Newer Multiparametric Prognostic and Predictive Markers for Breast Cancer Dennis Sgroi, MD
2:00 pm International Guidelines for pCR or Updates to Staging Fraser Symmans, MD
2:30 pm Lobular Carcinoma in Situ (LCIS) Current Concepts and Challenges Tari King, MD
3:00 pm Questions and Answers
3:15pm Break
Session 3: Challenging Clinical Cases Moderator: William Gradishar, MD 3:45 pm Case Discussions Confirmed Faculty 5:00 pm Adjourn
5:00 – 6:00 pm Welcome Reception
7:30 am Breakfast & Exhibits
Session 4: Imaging and Risk Session Chair: Sarah Friedewald, MD
8:30 am Refining Indications for PET Scanning: Present and Future Gary Ulaner, MD
9:00 am MRI: What is the Evidence? Lawrence Solin, MD
9:30 am Understanding and Managing Genetic Risk Beyond BRCA Mark Robson, MD
10:00 am Break
10:30 am Topical Approaches to Chemoprevention Seema Khan, MD
11:00 am Questions and Answers
11:15 am LYNN SAGE DISTINGUISHED LECTURER TARGETING THE BREAST CANCER GENOME AND THE SHAPING OF PRECISION MEDICINE Jose Baselga, MD, PhD
12:15 am Lunch Break
Session 5: Current Issues in Surgery and Adjuvant Therapy Session Chair: Seema Khan, MD
1:30 pm Adjuvant Considerations in Premenopausal Women Ruth O’Regan, MD
2:00 pm Fat Grafting: Indications, Safety, Results Malcolm Kell, MD
2:30 pm TN Breast Cancer: Where are We Now? Joyce O’Shaughnessy, MD, PhD
3:00 pm Break
3:30 pm Oncoplastic Surgery or Mastectomy and Reconstruction: Which is the Best Choice? Elizabeth Mittendorf, MD, PhD 4:00 pm What is the Optimal Duration of Endocrine Therapy? William Gradishar, MD
4:30 pm Making Endocrine Therapy Better V. Craig Jordan, OBE, PhD, DSc
5:00 pm Questions and Answers
5:15 pm Adjourn
SEPTEMBER 15 FRIDAY
7:30 am Breakfast & Exhibits
Session 6: Challenging Clinical Scenarios Session Chair: Massimo Cristofanilli, MD
8:30 am Overcoming Resistance in ER+ Disease Massimo Cristofanilli, MD
9:00 am Surgery or RT for Oligometastases Thomas Buchholz, MD
9:30 am Sequencing of HER-2 Therapy Harold Burstein, MD, PhD
10:00 am Break
10:30 am Controversies in DCIS Management Richard Bleicher, MD
11:00 am Questions and Answers
11:15 am THE CONNIE MOSKOW MEMORIAL LECTURE: BREAST CANCER AS A GLOBAL DISEASE – ARE WE UP TO THE CHALLENGE? Benjamin Anderson, MD
12:15 pm Lunch Break
Session 7: Breast Cancer in the Elderly and Reconstructive Issues Session Chair: Monica Morrow, MD
1:30 pm Why do We Need Geriatric Assessment? Arti Hurria, MD
1:50 pm Local Therapy Issues in Elders Kevin Hughes, MD
2:10 pm Adjuvant Therapy for HER-2+ and TN cancer in Elders Hyman Muss, MD
2:30 pm Selecting the Right Reconstruction for the Right Patient John Kim, MD
2:50 pm Reconstruction and Radiation Reshma Jagsi, MD, PhD
3:10 pm Questions and Answers
3:30 pm Break
3:45 pm Multidisciplinary Tumor Board Monica Morrow, MD
5:00 pm Adjourn
SEPTEMBER 16 SATURDAY
Session 8: Neoadjuvant Controversies Session Chair: William Gradishar, MD
8:30 am Predicting Response to NAC Melinda Telli, MD
9:00 am Selecting Operable Patients for Primary Surgery vs NAC Monica Morrow, MD
9:30 am Managing Residual Disease after NAC Lajos Pusztai, MD, PhD
10:00 am RT after NAC: What to do While Awaiting Trial Results? Abram Recht, MD
11:00 am Adjourn
SEPTEMBER 17 SUNDAY
Registration Advance registration is encouraged, as space and materials are limited. The registration fee includes conference tuition, CME credits, materials, four breakfasts, breaks and an evening reception.
Type Discounted Regular Through July 31 After July 31
General $525 $625
Fellow/Student/Trainee $275 $375
Nurse/Physician Assistant/Nurse Practitioner $275 $375
Industry Representative $725 $825
ADDITIONAL FEES
Lunch Ticket (no refunds) $25/day
Breakout Session Ticket $50/day
Refund/Cancelation Policy Registration fees less a $50 administrative handling fee are refundable if a written request is received on or before August 18, 2017. For further information, please call 312.695.1392 or email [email protected].
Award ProgramsThe Lynn Sage Symposium Scholars Program is available for fellows and residents, and the Chicago Sister Cities Medical Initiative Program is available for international physicians. Detailed information on these award programs and application processes is available online at lynnsagebreastcancer.org. Awards are made possible through the generous support of the Lynn Sage Cancer Research Foundation.